Please login to the form below

Not currently logged in
Email:
Password:

Bayer appoints president of Americas pharma business

Dr Carsten Brunn to lead operations across the US, Canada, Central and Latin America

Bayer Dr Carsten BrunnBayer has appointed Dr Carsten Brunn as the president of its pharmaceuticals business in the Americas, overseeing the company's operations in the US, Canada and Central and Latin America.

Dr Brunn first joined Bayer in 2011 as global head of primary care, based in Beijing, China, and has subsequently served as head of Bayer's pharmaceuticals commercial operations in Japan since 2013.

Prior to this, Dr Brunn was vice president of pharma, Asia-Pacific at Bausch & Lomb and served as global head of marketing at Basilea Pharmaceutica International, based in Basel, Switzerland.

He also brings branding and sales leadership experience from Novartis and Eli Lilly, and recently served as chairman of European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan.

Dieter Weinand, president of Bayer's pharmaceutical division, said: “Carsten is a strategic and highly respected leader in the pharmaceutical industry and I'm delighted to have him lead the company's largest pharmaceutical business worldwide.

“Carsten's global perspective and proven track record of successful operational executive at the local level will be a critical asset to us as we continue to build on our current momentum in the US and across the Americas region.”

26th January 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics